Claudin18.2 Identifies a Previously Undefined Patient Population with Gastric/GEJ Cancer
Time: 11:30 am
day: Day 2 Track B AM
Details:
- Claudin 18.2 is a tight junction protein that during transformation is retained and exposed for detection
- Claudin 18.2 can be detected by IHC and is prevalent in a significant percentage of patients
- The biomarker Claudin 18.2 may guide treatment decisions in these patients
